- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy for type 1 diabetes
Authors
Keywords
-
Journal
BRITISH MEDICAL BULLETIN
Volume 140, Issue 1, Pages 76-90
Publisher
Oxford University Press (OUP)
Online
2021-12-07
DOI
10.1093/bmb/ldab027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
- (2021) Emily K. Sims et al. Science Translational Medicine
- Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2021) Matthias von Herrath et al. Lancet Diabetes & Endocrinology
- A Comparison of Familial and Sporadic Type 1 Diabetes Among Young Patients
- (2021) Beate Karges et al. DIABETES CARE
- Defining a cure for type 1 diabetes: a call to action
- (2021) Bart O Roep et al. Lancet Diabetes & Endocrinology
- Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany
- (2020) Anette-Gabriele Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High residual C-peptide likely contributes to glycemic control in type 1 diabetes
- (2020) Michael R. Rickels et al. JOURNAL OF CLINICAL INVESTIGATION
- A combined risk score enhances prediction of type 1 diabetes among susceptible children
- (2020) Lauric A. Ferrat et al. NATURE MEDICINE
- Different Interaction of Onset Age and Duration of Type 1 Diabetes on the Dynamics of Autoantibodies to IA‐2 and ZnT8
- (2020) Eiji Kawasaki et al. Journal of Diabetes Investigation
- Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes
- (2020) Simona Ghetti et al. DIABETES CARE
- Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications
- (2020) Anita Jeyam et al. DIABETES CARE
- Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
- (2020) Teresa Quattrin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis
- (2019) Seth A. Sharp et al. DIABETES CARE
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis
- (2019) Maaret Turtinen et al. DIABETOLOGIA
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
- (2019) Anette-Gabriele Ziegler et al. BMJ Open
- Microbiome and type 1 diabetes
- (2019) Heli Siljander et al. EBioMedicine
- Changing the landscape for type 1 diabetes: the first step to prevention
- (2019) Colin M Dayan et al. LANCET
- C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase
- (2018) Beverley M. Shields et al. DIABETES CARE
- Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1cin New-Onset Type 1 Diabetes
- (2018) Michael J. Haller et al. DIABETES CARE
- Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics
- (2018) Gordon C Weir et al. PEDIATRIC DIABETES
- Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
- (2018) Araz Rawshani et al. LANCET
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives
- (2017) Emanuele Bosi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial
- (2017) Helena Elding Larsson et al. PEDIATRIC DIABETES
- Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)
- (2017) Takuya Awata et al. Diabetes Therapy
- Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)
- (2017) Takuya Awata et al. Diabetes Therapy
- Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA 1c , and Insulin Dose
- (2016) Wei Hao et al. DIABETES CARE
- Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression
- (2016) Christian Hundhausen et al. Science Translational Medicine
- Excess mortality in Type 1 diabetes diagnosed in childhood and adolescence: a systematic review of population-based cohorts
- (2015) Eileen Morgan et al. ACTA DIABETOLOGICA
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
- (2015) Richard A. Insel et al. DIABETES CARE
- Current Concepts on the Pathogenesis of Type 1 Diabetes—Considerations for Attempts to Prevent and Reverse the Disease
- (2015) Mark A. Atkinson et al. DIABETES CARE
- Predicting Type 1 Diabetes Using Biomarkers
- (2015) Ezio Bonifacio DIABETES CARE
- Prevention and Reversal of Type 1 Diabetes—Past Challenges and Future Opportunities
- (2015) Jay S. Skyler DIABETES CARE
- Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
- (2015) Shona J. Livingstone et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Timing of Gluten Introduction and Islet Autoimmunity in Young Children: Updated Results From the BABYDIET Study: Table 1
- (2014) Andreas Beyerlein et al. DIABETES CARE
- Hydrolyzed Infant Formula and Early β-Cell Autoimmunity
- (2014) Mikael Knip et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes
- (2014) Michael J. Haller et al. JOURNAL OF CLINICAL INVESTIGATION
- Maternal anxiety about a child's diabetes risk in the TEDDY study: the potential role of life stress, postpartum depression, and risk perception
- (2014) Roswith Roth et al. PEDIATRIC DIABETES
- Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study
- (2014) D. Dabelea et al. PEDIATRICS
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- Residual -Cell Function 3-6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents
- (2013) J. S. Sorensen et al. DIABETES CARE
- The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
- (2013) Richard A. Oram et al. DIABETOLOGIA
- The prenatal environment and type 1 diabetes
- (2013) L. C. Stene et al. DIABETOLOGIA
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- (2013) Anette G. Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
- (2013) Mark R Rigby et al. Lancet Diabetes & Endocrinology
- Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study
- (2012) Outi Vaarala et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Breast-Feeding and Childhood-Onset Type 1 Diabetes: A pooled analysis of individual participant data from 43 observational studies
- (2012) C. R. Cardwell et al. DIABETES CARE
- Reduced Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Young Children Participating in Longitudinal Follow-Up
- (2011) H. Elding Larsson et al. DIABETES CARE
- Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children
- (2011) Anette-G. Ziegler et al. JOURNAL OF AUTOIMMUNITY
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus
- (2010) Douglas O. Sobel et al. ACTA DIABETOLOGICA
- Residual Insulin Production and Pancreatic -Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
- (2010) H. A. Keenan et al. DIABETES
- β-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up
- (2010) Maria Thunander et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity
- (2010) Mikael Knip et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction and prevention of Type 1 diabetes mellitus
- (2010) Li ZHANG et al. Journal of Diabetes
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- Protective effects of 1-α-hydroxyvitamin D3 on residual β-cell function in patients with adult-onset latent autoimmune diabetes (LADA)
- (2009) Xia Li et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes
- (2009) C.-D. Agardh et al. DIABETOLOGIA
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
- (2009) Jeffrey C Barrett et al. NATURE GENETICS
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosiglitazone preserves islet β-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study
- (2008) Zhifang Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- (2008) Kirsti Näntö-Salonen et al. LANCET
- Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
- (2008) C. Louvet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started